Literature DB >> 25959581

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles.

V Pengo1, A Ruffatti2, M Tonello2, A Hoxha3, E Bison3, G Denas3, S Padayattil Jose3, G Zoppellaro3, A Bracco3, A Banzato3.   

Abstract

BACKGROUND: Determination of the three recommended tests for the diagnosis of antiphospholipid syndrome [Lupus Anticoagulant (LA), anticardiolipin (aCL) and anti β2-Glycoprotein 1 (aβ2GP1) antibodies] allow physicians to allocate patients into classification (risk) categories.
OBJECTIVES: To measure antibodies of IgG isotype directed towards Domain 4/5 (Dm4/5) of β2GP1. PATIENTS/
METHODS: In this cross-sectional study we measured IgG aβ2GP1-Dm4/5 in a group of individuals positive for IgG aβ2GP1 and classified as triple (LAC+, IgG aCL+, IgG aβ2GP1+, n=32), double (LAC-, IgG aCL+, IgG aβ2GP1+, n=23) or single positive (LA-, IgG aCL-, IgG aβ2GP1+, n=10).
RESULTS: Geometric mean and standard deviation of IgG aβ2GP1 values expressed as Chemiluminescent Units (CU) in triple, double, single positive groups and in 40 healthy individuals were 1795±783, 321±181, 29±8 and 5.0±1.0, respectively (ANOVA p<0.0001). Geometric mean and standard deviation of IgG aβ2GP1-Dm4/5 expressed as Optical Density (OD) in triple, double and single positive groups and in 40 healthy individuals were 0.16±0.13, 0.16±0.15 and 0.26±0.15, 0.13±0,11, respectively (ANOVA p<0.002). Individuals in the single positive group, expressed significantly higher values with respect to triple (p=0.04) and double (p=0.03) positive groups. Approximate OD cut-off value (99° percentile) calculated in 40 normal control subjects is 0.404. Positivity to IgG aβ2GP1-Dm4/5 according to this cutoff was found in only 5 individuals, 3 in triple positive and 2 in single positive groups and was not associated with thromboembolism.
CONCLUSION: Mean level of IgG aβ2GP1-Dm4/5 is higher in single positive group. There is no association between positivity to IgG aβ2GP1-Dm4/5 and thromboembolic events.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; Antiphospholipid syndrome; Epitopes; Glycoproteins; Thrombosis

Mesh:

Substances:

Year:  2015        PMID: 25959581     DOI: 10.1016/j.thromres.2015.04.031

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

Review 1.  Obstetric Anti-phospholipid Syndrome: State of the Art.

Authors:  Maria Chiara Gerardi; Melissa Alexandre Fernandes; Angela Tincani; Laura Andreoli
Journal:  Curr Rheumatol Rep       Date:  2018-08-13       Impact factor: 4.592

2.  Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome.

Authors:  Shulan Zhang; Ziyan Wu; Si Chen; Jing Li; Xiaoting Wen; Liubing Li; Wen Zhang; Jiuliang Zhao; Fengchun Zhang; Yongzhe Li
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

Review 3.  Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.

Authors:  Savino Sciascia; Simone Baldovino; Karen Schreiber; Laura Solfietti; Massimo Radin; Maria J Cuadrado; Elisa Menegatti; Doruk Erkan; Dario Roccatello
Journal:  Clin Mol Allergy       Date:  2016-07-15

4.  Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.

Authors:  Florian Posch; Johanna Gebhart; Jacob H Rand; Silvia Koder; Peter Quehenberger; Vittorio Pengo; Cihan Ay; Ingrid Pabinger
Journal:  BMC Med       Date:  2017-03-10       Impact factor: 8.775

5.  New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats.

Authors:  Paolo Durigutto; Claudia Grossi; Maria Orietta Borghi; Paolo Macor; Francesca Pregnolato; Elena Raschi; Michael P Myers; Philip G de Groot; Pier Luigi Meroni; Francesco Tedesco
Journal:  Haematologica       Date:  2018-11-15       Impact factor: 9.941

6.  Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Authors:  Dirk Roggenbuck; Maria Orietta Borghi; Valentina Somma; Thomas Büttner; Peter Schierack; Katja Hanack; Claudia Grossi; Caterina Bodio; Paolo Macor; Philipp von Landenberg; Francesco Boccellato; Michael Mahler; Pier Luigi Meroni
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.